CurrentRheuma
Get Weekly

Topic · page 2 of 8

Autoinflammatory & rare systemic diseases

Adult-onset Still's disease, periodic fever syndromes, other monogenic and acquired autoinflammatory disease, IgG4-related disease, relapsing polychondritis, sarcoidosis with joint involvement and other rare systemic inflammatory disease

Briefs 41–80 of 305 placed here, newest publication first

Briefs in Autoinflammatory & rare systemic diseases

Newest publication first

  1. N Engl J Med

    Obexelimab for the Treatment of IgG4-Related Disease

    Randomized controlled trial

  2. Rheumatology (Oxford)

    Reduced follicular helper T cells in peripheral blood marks a distinct feature of retroperitoneal fibrosis

    Mechanistic study

  3. RMD Open

    Potential stratification of TAFRO syndrome by anti-SS-A antibodies status and therapeutic response to rituximab

    Meta-analysis

  4. RMD Open

    Clinical phenotype and laboratory markers in patients affected by haploinsufficiency of A20 (HA20): a case series from two Italian centres

    Cohort study

  5. Ann Rheum Dis

    Broad screening of inflammation-associated proteins identifies serum CCL19 as a novel biomarker of disease activity in IgG4-related disease

    Diagnostic or prognostic study

  6. Arthritis Rheumatol

    A Rare RIPK3 Variant Enhances Necroptosis and Promotes Inflammation in a Still Disease–Like Autoinflammatory Syndrome

    Mechanistic study

  7. Scand J Rheumatol

    Treatment outcomes and predictors of macrophage activation syndrome in adult-onset Still’s disease: a 24 year single-centre experience

    Cohort study

  8. Rheumatology (Oxford)

    Autoantibody reactome analysis reveals novel biomarkers for idiopathic retroperitoneal fibrosis

    Diagnostic or prognostic study

  9. Rheumatology (Oxford)

    Cross-national biologic treatment guidelines for FMF: a comparative analysis

    Cross-sectional study

  10. Clin Exp Rheumatol

    Outcome and risk factors for progression in IgG4-related disease under watchful waiting

    Cohort study

  11. Rheumatology (Oxford)

    Amyloidosis secondary to familial Mediterranean fever: machine learning–based prediction models

    Cohort study

  12. Rheumatology (Oxford)

    The effect of IL-1 blockers on exertional leg pain in familial Mediterranean fever patients: an exploratory study

    Cohort study

  13. Rheumatology (Oxford)

    Spectrum and significance of 18F-FDG-PET/CT abnormalities in VEXAS syndrome

    Cohort study

  14. Arthritis Rheumatol

    Landscape of Somatic Mutations in a Large Cohort of Chinese Patients With Immune Dysregulations

    Cross-sectional study

  15. Arthritis Rheumatol

    A Multifaceted Interplay Among Hemophagocytosis, Interleukin‐18, and Type I Interferon Distinguishes Still Disease From Other Autoinflammatory Diseases

    Mechanistic study

  16. Ann Rheum Dis

    Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study

    Cohort study

  17. J Rheumatol

    Differentiating Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA) and Syndrome of Undifferentiated Recurrent Fever (SURF): A Comparative Study of Clinical Features, Treatment Response, and Remission

    Cohort study

  18. Arthritis Rheumatol

    Deficiency of AP1M2 Causes a New Autoinflammatory Disease With Colitis

    Mechanistic study

  19. Rheumatology (Oxford)

    Cumulative defined daily doses enable objective assessment of treatment intensity and outcome prediction in immunoglobulin G4-related disease and its subtypes

    Cohort study

  20. Lancet Rheumatol

    Development and validation of clinical criteria for the definition of disease activity in adult-onset Still's disease: a cohort study

    Cohort study

  21. Clin Exp Rheumatol

    Predictors of mortality in sarcoidosis: a nationwide cohort study from the SARCOGEAS registry

    Cohort study

  22. Rheumatology (Oxford)

    Urological manifestations in familial Mediterranean fever excluding renal amyloidosis: a systematic review

    Meta-analysis

  23. Arthritis Rheumatol

    First‐Year IgG Dynamics in IgG4 ‐Related Disease: A Critical Window for Predicting Long‐Term Outcomes

    Cohort study

  24. Arthritis Res Ther

    Identification of candidate biomarkers for diagnosis, disease activity, and relapse prediction in IgG4-related disease

    Diagnostic or prognostic study

  25. Arthritis Rheumatol

    Interleukin‐18 Levels Are Associated With Disease Course in Patients With Still Disease Treated With Interleukin‐1 Inhibitors

    Cohort study

  26. Clin Exp Rheumatol

    An association study suggests that PTPN22 and TNFAIP3, but not STAT4, are risk factors for IgG4-related disease

    Research article

  27. RMD Open

    [ 18 F]FAPI PET/CT-based scoring systems for patient assessment in IgG4-related disease

    Diagnostic or prognostic study

  28. Rheumatology (Oxford)

    IgG4 surge and relapse: determining the predictive threshold for IgG4 rising kinetics in IgG4-related disease

    Cohort study

  29. Clin Exp Rheumatol

    IgG4-related Castleman disease: clinical-pathological features and therapeutic implications

    Cohort study

  30. Arthritis Rheumatol

    Distinct Natural Killer Cell Signature in Still Disease: Insights From a Multinational Immunome Project Consortium for Autoinflammatory Disorders

    Mechanistic study

  31. RMD Open

    Colchicine resistance prediction criteria from the TURPAID cohort do not apply to the JIR cohort: a multicentre descriptive analysis

    Cohort study

  32. Rheumatology (Oxford)

    Machine-learning algorithms for predicting colchicine resistance in Familial Mediterranean Fever

    Cohort study

  33. Arthritis Care Res (Hoboken)

    Performance Characteristics of Anti–Collagen II Antibodies in Relapsing Polychondritis and Related Diseases: Prospective Analysis, Systematic Review, and Meta‐Analysis

    Meta-analysis

  34. Arthritis Res Ther

    Reassessing the role of watchful waiting strategy for IgG4-related disease: a real-world study

    Cohort study

  35. Rheumatology (Oxford)

    Clinical impact of whole-exome sequencing: 10 years of the Great Ormond Street Hospital Autoinflammation Centre of Excellence experience

    Cohort study

  36. Rheumatology (Oxford)

    Long-term safety and efficacy of tocilizumab in adult-onset Still’s disease: open-label, long-term extension of the phase III trial

    Research article

  37. Semin Arthritis Rheum

    IgG4 related coronary artery involvement: A scoping review of the literature

    Research article

  38. Semin Arthritis Rheum

    VEXAS syndrome and cancer: Insights about a possible “Tip of the Iceberg”. Ambidirectional data from the international AIDA network registries

    Cohort study

  39. Rheumatology (Oxford)

    Characterization of latent allergen profile and association with clinical features in patients with IgG4-related disease

    Cross-sectional study

  40. Rheumatology (Oxford)

    Greyscale, colour Doppler and oscillometric macroangiopathy indices in patients with autoinflammatory syndromes: the INFLAMMACARD cohort

    Cross-sectional study

All 305 Briefs in ExploreShowing Briefs 41–80 of 305, newest first